Articles

UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (356) 356
science & technology (353) 353
life sciences & biomedicine (333) 333
infectious diseases (255) 255
male (229) 229
adult (205) 205
female (201) 201
hiv (177) 177
middle aged (173) 173
hiv infections - drug therapy (162) 162
biological and medical sciences (129) 129
medical sciences (123) 123
immunology (118) 118
hiv infections - complications (109) 109
virology (108) 108
viral diseases (104) 104
human immunodeficiency virus--hiv (98) 98
human viral diseases (94) 94
hepatitis c (86) 86
aids/hiv (84) 84
microbiology (81) 81
treatment outcome (81) 81
antiviral agents (77) 77
viral load (77) 77
hiv infections - virology (76) 76
viral diseases of the lymphoid tissue and the blood. aids (76) 76
aged (65) 65
antiviral agents - therapeutic use (64) 64
anti-hiv agents - therapeutic use (61) 61
hepatitis (59) 59
drug therapy (58) 58
pharmacology & pharmacy (58) 58
drug therapy, combination (57) 57
hiv infections - immunology (57) 57
risk factors (55) 55
cd4 lymphocyte count (54) 54
hiv infection (54) 54
young adult (54) 54
health aspects (50) 50
pharmacology. drug treatments (50) 50
antiretroviral drugs (47) 47
hepatitis c virus (47) 47
genotype (46) 46
gastroenterology & hepatology (45) 45
hepatitis c - drug therapy (45) 45
infections (45) 45
hepatitis c - complications (44) 44
antiretroviral therapy (43) 43
viral hepatitis (43) 43
antibiotics. antiinfectious agents. antiparasitic agents (42) 42
antiretroviral therapy, highly active (42) 42
highly active antiretroviral therapy (40) 40
adolescent (39) 39
cohort studies (39) 39
research (39) 39
aids (37) 37
hepatitis c, chronic - drug therapy (37) 37
hiv patients (37) 37
analysis (36) 36
rna, viral - blood (36) 36
abridged index medicus (35) 35
comorbidity (35) 35
care and treatment (34) 34
hepacivirus - genetics (34) 34
prospective studies (34) 34
disease progression (33) 33
hiv infections - epidemiology (33) 33
virus diseases (33) 33
human immunodeficiency virus (32) 32
immunodeficiencies (32) 32
immunodeficiencies. immunoglobulinopathies (32) 32
immunopathology (32) 32
europe (30) 30
viruses (30) 30
acquired immune deficiency syndrome--aids (29) 29
hepatitis c, chronic - complications (29) 29
hiv-1 (29) 29
liver diseases (29) 29
ribavirin - therapeutic use (29) 29
medicine (28) 28
fundamental and applied biological sciences. psychology (27) 27
clinical trials (26) 26
general & internal medicine (26) 26
hepatitis c - epidemiology (26) 26
liver (26) 26
medicine, general & internal (26) 26
tenofovir (26) 26
hiv-1 - drug effects (25) 25
hiv-1 - genetics (25) 25
interferon-alpha - therapeutic use (25) 25
research article (25) 25
coinfection - drug therapy (24) 24
hcv (24) 24
interferon (24) 24
mortality (24) 24
anti-hiv agents - administration & dosage (23) 23
coinfection (23) 23
dosage and administration (23) 23
patients (23) 23
retrospective studies (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text HCV reinfection incidence and spontaneous clearance rates in HIV-positive men who have sex with men in Western Europe
by Ingiliz, Patrick and Martin, Thomas C and Rodger, Alison and Stellbrink, Hans-Jürgen and Mauss, Stefan and Boesecke, Christoph and Mandorfer, Mattias and Bottero, Julie and Baumgarten, Axel and Bhagani, Sanjay and Lacombe, Karine and Nelson, Mark and Rockstroh, Jürgen K and NEAT study group and NEAT Study Grp
Journal of hepatology, ISSN 0168-8278, 2016, Volume 66, Issue 2, pp. 282 - 287
Gastroenterology and Hepatology | HCV therapy | Spontaneous clearance | HIV-HCV coinfection | Acute hepatitis C | HCV reinfection | SVR | Gastroenterology & Hepatology | Life Sciences & Biomedicine | Science & Technology | Hepacivirus - isolation & purification | Communicable Disease Control - statistics & numerical data | Hepatitis C - drug therapy | Antiviral Agents - therapeutic use | HIV Infections - epidemiology | HIV Infections - virology | Humans | Middle Aged | Europe - epidemiology | Male | Coinfection - epidemiology | Incidence | Homosexuality, Male | Hepatitis C - epidemiology | Hepatitis C - virology | HIV Seropositivity - epidemiology | Adult | Female | HIV Infections - drug therapy | Hepatitis C virus | HIV (Viruses) | HIV patients | Mens health | Hepatitis | Risk groups | Human immunodeficiency virus--HIV | Sex | Interferon | Hepatitis C | Morbidity | Ribavirin | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Highlights of the 2017 European AIDS Clinical Society (EACS) Guidelines for the treatment of adult HIV-positive persons version 9.0
by Ryom, L and Boesecke, C and Bracchi, M and Ambrosioni, J and Pozniak, A and Arribas, J and Behrens, G and Mallon, P. G. M and Puoti, M and Rauch, A and Miro, J. M and Kirk, O and Marzolini, C and Lundgren, J. D and Battegay, M and Reiss, Peter and EACS Governing Board and the EACS Governing Board
HIV medicine, ISSN 1464-2662, 2018, Volume 19, Issue 5, pp. 309 - 315
ART | comorbidities | HIV | opportunistic diseases | coinfections | European AIDS Clinical Society guidelines | HCV | antiretroviral treatment | HBV | Life Sciences & Biomedicine | Infectious Diseases | Science & Technology | Liver diseases | Comorbidity | Vaccination | Practice guidelines (Medicine) | HIV patients | HIV (Viruses) | Tenofovir | Highly active antiretroviral therapy | Tuberculosis | Transplantation of organs, tissues, etc | Respiratory tract diseases | Drug therapy | Hepatitis C virus | Hepatitis C | Health aspects | Distance learning | Toxicity | Liver | Lung transplantation | Switches | Viruses | Transplantation | Guidelines | Hepatitis | Fatty liver | Acquired immune deficiency syndrome--AIDS | Antiretroviral agents | Human immunodeficiency virus--HIV | Older people | Drug interaction | Antiviral agents | Medical treatment | Lung diseases | Drug interactions | Antiretroviral therapy | Pregnancy | Geriatrics | Computer assisted instruction--CAI | Index Medicus | European AIDS Clinical Society (EACS) Guideline
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Renal safety of tenofovir alafenamide vs. tenofovir disoproxil fumarate: a pooled analysis of 26 clinical trials
by Gupta, Samir K and Post, Frank A and Arribas, José R and Eron, Joseph J and Wohl, David A and Clarke, Amanda E and Sax, Paul E and Stellbrink, Hans-Jürgen and Esser, Stefan and Pozniak, Anton L and Podzamczer, Daniel and Waters, Laura and Orkin, Chloe and Rockstroh, Jürgen K and Mudrikova, Tatiana and Negredo, Eugenia and Elion, Richard A and Guo, Susan and Zhong, Lijie and Carter, Christoph and Martin, Hal and Brainard, Diana and SenGupta, Devi and Das, Moupali
AIDS (London), ISSN 0269-9370, 07/2019, Volume 33, Issue 9, pp. 1455 - 1465
Infectious Diseases | Immunology | Life Sciences & Biomedicine | Science & Technology | Virology | Tenofovir | Medical research | Safety and security measures | Analysis | Clinical trials | Medicine, Experimental | Dosage and administration | Kidney diseases | Risk factors | Index Medicus | AIDS/HIV | drug safety biomarkers | Clinical Science | HIV | proximal renal tubular dysfunction | adverse drug event | tenofovir disoproxil fumarate | renal fanconi syndrome | HAART
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Hepatitis C (HCV) microelimination in HIV-coinfected men who have sex with men (MSM): A low hanging fruit?
by Rockstroh, Jürgen Kurt
Clinical infectious diseases, ISSN 1058-4838, 08/2020
Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Noninvasive Markers for Monitoring Fibrosis Regression After Hepatitis C Virus Cure: What Do They Promise?
by Rockstroh, Jürgen Kurt
Clinical infectious diseases, ISSN 1058-4838, 06/2020
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Interview with Professor Jürgen Rockstroh, director of the Bonn University Clinic. Atazanavir in general practice
by Rockstroh, Jürgen
MMW Fortschritte der Medizin, ISSN 1438-3276, 04/2004, Volume 146 Spec No 1, pp. 18 - 19
HIV Protease Inhibitors - adverse effects | Pyridines - administration & dosage | Drug Administration Schedule | Humans | Drug Approval | HIV Protease Inhibitors - administration & dosage | Oligopeptides - adverse effects | Pyridines - adverse effects | Atazanavir Sulfate | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Drug Therapy, Combination | Delayed-Action Preparations | Index Medicus
Journal Article
Details down arrow
7. Full Text Hepatitis C Virus Treatment as Prevention: Challenges and Opportunities in Men Who Have Sex With Men
by Rockstroh, Jürgen Kurt and Boesecke, Christoph
The Journal of infectious diseases, ISSN 0022-1899, 11/2020, Volume 222, Issue 9, pp. S782 - S788
reinfection | HCV | HIV | microelimination | DAA therapy | Hepatitis | Ribonucleic acid--RNA | Hepatitis C | Anal sex | Human immunodeficiency virus--HIV | Prophylaxis | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Impact of CYP2B6 983T>C polymorphism on non-nucleoside reverse transcriptase inhibitor plasma concentrations in HIV-infected patients
by Wyen, Christoph and Hendra, Heidy and Vogel, Martin and Hoffmann, Christian and Knechten, Heribert and Brockmeyer, Norbert H and Bogner, Johannes R and Rockstroh, Jürgen and Esser, Stefan and Jaeger, Hans and Harrer, Thomas and Mauss, Stefan and van Lunzen, Jan and Skoetz, Nicole and Jetter, Alexander and Groneuer, Christiane and Fätkenheuer, Gerd and Khoo, Saye H and Egan, Deirdre and Back, David J and Owen, Andrew and German Competence Network HIVAIDS and German Competence Network for HIV/AIDS and on behalf of the German Competence Network for HIV/AIDS
Journal of antimicrobial chemotherapy, ISSN 0305-7453, 4/2008, Volume 61, Issue 4, pp. 914 - 918
Pharmacogenetics | Drug disposition | Metabolism | Pharmacokinetics | NNRTIs | Pharmacology & Pharmacy | Infectious Diseases | Life Sciences & Biomedicine | Microbiology | Science & Technology | Immunopathology | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Immunodeficiencies. Immunoglobulinopathies | Immunodeficiencies | Antibiotics. Antiinfectious agents. Antiparasitic agents | Multivariate Analysis | Oxidoreductases, N-Demethylating - genetics | Age Factors | Reverse Transcriptase Inhibitors - blood | Humans | Middle Aged | Aryl Hydrocarbon Hydroxylases - genetics | Male | Nevirapine - therapeutic use | Chromatography, High Pressure Liquid | Nevirapine - blood | Reverse Transcriptase Inhibitors - pharmacokinetics | Benzoxazines - pharmacokinetics | Polymerase Chain Reaction | Aged, 80 and over | Adult | Benzoxazines - blood | Female | Reverse Transcriptase Inhibitors - therapeutic use | Body Mass Index | Gene Frequency | European Continental Ancestry Group | Benzoxazines - therapeutic use | Polymorphism, Genetic | HIV Infections - drug therapy | Aged | African Continental Ancestry Group | Nevirapine - pharmacokinetics | Cytochrome P-450 CYP2B6 | Genotype & phenotype | Human immunodeficiency virus--HIV | Whites | Blacks | Bioavailability | Antiviral drugs | Polymorphism | Index Medicus | pharmacokinetics | drug disposition | metabolism | pharmacogenetics
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Influence of Hepatitis C Virus Infection on HIV-1 Disease Progression and Response to Highly Active Antiretroviral Therapy
by Jürgen K. Rockstroh and Amanda Mocroft and Vincent Soriano and Cristina Tural and Marcello H. Losso and Andrzej Horban and Ole Kirk and Andrew Phillips and Bruno Ledergerber and Jens Lundgren and EuroSIDA Study Group
The Journal of infectious diseases, ISSN 0022-1899, 9/2005, Volume 192, Issue 6, pp. 992 - 1002
HIV/AIDS | Highly active antiretroviral therapy | Coinfection | RNA | HIV | Liver | AIDS | Infections | Hepacivirus | HIV 1 | Diseases | Fundamental and applied biological sciences. Psychology | Miscellaneous | Viral hepatitis | Infectious diseases | Microbiology | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Virology | HIV Infections - virology | Humans | Middle Aged | Risk Factors | Male | RNA, Viral - blood | CD4 Lymphocyte Count | Disease Progression | Antiretroviral Therapy, Highly Active | HIV Infections - immunology | Hepatitis C - immunology | HIV-1 - isolation & purification | Hepatitis C Antibodies - blood | Hepatitis C - mortality | HIV Infections - complications | Survival Analysis | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Infections - drug therapy | Hepatitis C - complications | Cohort Studies | Antiviral agents | Dosage and administration | Liver diseases | Diagnosis | Drug therapy | Hepatitis C | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Weight Gain Following Initiation of Antiretroviral Therapy: Risk Factors in Randomized Comparative Clinical Trials
by Sax, Paul E and Erlandson, Kristine M and Lake, Jordan E and Mccomsey, Grace A and Orkin, Chloe and Esser, Stefan and Brown, Todd T and Rockstroh, Jürgen K and Wei, Xuelian and Carter, Christoph C and Zhong, Lijie and Brainard, Diana M and Melbourne, Kathleen and Das, Moupali and Stellbrink, Hans-Jürgen and Post, Frank A and Waters, Laura and Koethe, John R
Clinical infectious diseases, ISSN 1058-4838, 09/2020, Volume 71, Issue 6, pp. 1379 - 1389
ART | HIV | antiretroviral therapy | obesity | weight gain | Infectious Diseases | Immunology | Life Sciences & Biomedicine | Microbiology | Science & Technology | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Full Text Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial
by DeJesus, Edwin and Rockstroh, Jürgen K, MD and Henry, Keith, MD and Molina, Jean-Michel, MD and Gathe, Joseph, MD and Ramanathan, Srinivasan, PhD and Wei, Xuelian, PhD and Yale, Kitty, MSc and Szwarcberg, Javier, MD and White, Kirsten, Prof and Cheng, Andrew K, MD and Kearney, Brian P, Prof and GS-236-0103 Study Team
The Lancet (British edition), ISSN 0140-6736, 2012, Volume 379, Issue 9835, pp. 2429 - 2438
Internal Medicine | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | Antiviral agents | General aspects | Infectious diseases | Pharmacology. Drug treatments | Viral diseases | Viral diseases of the lymphoid tissue and the blood. Aids | Biological and medical sciences | Medical sciences | Human viral diseases | Antibiotics. Antiinfectious agents. Antiparasitic agents | HIV-1 | Humans | Middle Aged | Male | Thiazoles - administration & dosage | Carbamates - administration & dosage | Anti-HIV Agents - administration & dosage | Tenofovir | Atazanavir Sulfate | Adult | Female | Emtricitabine | Adenine - analogs & derivatives | Pyridines - administration & dosage | Double-Blind Method | Ritonavir - administration & dosage | Deoxycytidine - administration & dosage | Adenine - administration & dosage | Organophosphonates - administration & dosage | Quinolones - administration & dosage | HIV Infections - drug therapy | Oligopeptides - administration & dosage | Cobicistat | Deoxycytidine - analogs & derivatives | Drug Combinations | Patient outcomes | Dosage and administration | Research | Comparative analysis | Drug therapy | HIV infection | Anti-HIV agents | Antiretroviral drugs | Bone density | Pharmaceutical industry | Human immunodeficiency virus--HIV | Pneumonia | Laboratories | Ritonavir | Liver | Infections | Drug resistance | Evidence-based medicine | Hepatitis | Randomization | All terrain vehicles | Creatinine | Integrase | Data processing | Proteinase inhibitors | Behavior disorders | Ribonucleic acid--RNA | Patients | Cholesterol | Glomerular filtration rate | Protease inhibitors | Interactive systems | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
12. Full Text Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study
by Rodger, Alison J and Cambiano, Valentina and Bruun, Tina and Vernazza, Pietro and Collins, Simon and Degen, Olaf and Corbelli, Giulio Maria and Estrada, Vicente and Geretti, Anna Maria and Beloukas, Apostolos and Raben, Dorthe and Coll, Pep and Antinori, Andrea and Nwokolo, Nneka and Rieger, Armin and Prins, Jan M and Blaxhult, Anders and Weber, Rainer and Van Eeden, Arne and Brockmeyer, Norbert H and Clarke, Amanda and del Romero Guerrero, Jorge and Raffi, Francois and Bogner, Johannes R and Wandeler, Gilles and Gerstoft, Jan and Gutiérrez, Felix and Brinkman, Kees and Kitchen, Maria and Ostergaard, Lars and Leon, Agathe and Ristola, Matti and Jessen, Heiko and Stellbrink, Hans-Jürgen and Phillips, Andrew N and Lundgren, Jens and Coll, Pep and Cobarsi, Patricia and Nieto, Aroa and Meulbroek, Michael and Carrillo, Antonia and Saz, Jorge and Guerrero, Jorge D.R and García, Mar Vera and Gutiérrez, Felix and Masiá, Mar and Robledano, Catalina and Leon, Agathe and Leal, Lorna and Redondo, Eva G and Estrada, Vicente P and Marquez, Rocio and Sandoval, Raquel and Viciana, Pompeyo and Espinosa, Nuria and Lopez-Cortes, Luis and Podzamczer, Daniel and Tiraboschi, Juan and Morenilla, Sandra and Antela, Antonio and Losada, Elena and Nwokolo, Nneka and Sewell, Janey and Clarke, Amanda and Kirk, Sarah and Knott, Alyson and Rodger, Alison J and Fernandez, Thomas and Gompels, Mark and Jennings, Louise and Ward, Lana and Fox, Julie and Lwanga, Julianne and Lee, Ming and Gilson, Richard and Leen, Clifford and Morris, Sheila and Clutterbuck, Dan and Brady, Michael and Asboe, David and Fedele, Serge and Fidler, Sarah and Brockmeyer, Norbert and Potthoff, Anja and Skaletz-Rorowski, Adriane and Bogner, Johannes and Seybold, Ulrich and Roider, Julia and Jessen, Heiko and Jessen, Arne and Ruzicic, Slobodan and Stellbrink, Hans-Jürgen and Kümmerle, Tim and Lehmann, Clara and Degen, Olaf and Bartel, Sindy and Hüfner, Anja and Rockstroh, Jürgen and Mohrmann, Karina and Boesecke, Christoph and ... and PARTNER Study Group and PARTNER Study Grp
The Lancet (British edition), ISSN 0140-6736, 06/2019, Volume 393, Issue 10189, pp. 2428 - 2438
Prospective Studies | Humans | Middle Aged | yes | Anti-HIV Agents/therapeutic use | Male | HIV Seropositivity/transmission | Viral Load | Antiretroviral Therapy, Highly Active | Homosexuality, Male | Unsafe Sex | Adult | Condoms | Sexual Partners | Medicine, General & Internal | Life Sciences & Biomedicine | General & Internal Medicine | Science & Technology | HIV Seropositivity - transmission | Anti-HIV Agents - therapeutic use | HIV patients | Disease transmission | HIV (Viruses) | Gay couples | Risk factors | Therapy | Sexually transmitted diseases--STD | Prophylaxis | Sex | Risk | Partnerships | Infections | Phylogeny | Incidence | Mathematical analysis | Antiretroviral agents | Human immunodeficiency virus--HIV | Drug therapy | Anal sex | Antiretroviral drugs | Sexual behavior | Health risks | Exposure | Ribonucleic acid--RNA | Seroconversion | Antiretroviral therapy | Data collection | Gays & lesbians | Index Medicus | Abridged Index Medicus | Medicin och hälsovetenskap
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights